MENU
CATX
AS OF
Feb 4, 12:28 PM (EDT)
Price
$5.02
Change
-$0.18 (-3.46%)
Capitalization
592.35M
50 days until earnings call
Intraday BUY SELL Signals
+Compare
CATX
Stock ticker: ASE
AS OF
Feb 4, 12:28 PM (EDT)
Price
$5.02
Change
-$0.18 (-3.46%)
Capitalization
592.35M

CATX Perspective Therapeutics Forecast, Technical & Fundamental Analysis

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology
CATX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CATX with price predictions
Feb 03, 2026

Momentum Indicator for CATX turns positive, indicating new upward trend

CATX saw its Momentum Indicator move above the 0 level on January 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where CATX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CATX just turned positive on January 29, 2026. Looking at past instances where CATX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

CATX moved above its 50-day moving average on January 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where CATX advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 163 cases where CATX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CATX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CATX broke above its upper Bollinger Band on February 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CATX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.446) is normal, around the industry mean (11.546). P/E Ratio (0.000) is within average values for comparable stocks, (38.420). CATX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). CATX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.000) is also within normal values, averaging (38.937).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CATX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CATX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CATX is expected to report earnings to rise 1.09% to -35 cents per share on March 26

Perspective Therapeutics CATX Stock Earnings Reports
Q4'25
Est.
$-0.35
Q3'25
Missed
by $0.03
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.30
The last earnings report on November 10 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 1.06M shares outstanding, the current market capitalization sits at 592.35M.
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRPDX79.061.60
+2.07%
Permanent Portfolio Permanent A
WAGSX12.16-0.07
-0.57%
Wasatch Global Select Investor
AWSIX17.08-0.12
-0.70%
Invesco Global Core Equity R5
TSTFX16.10-0.13
-0.80%
Transamerica Stock Index R4
AFGFX84.70-1.59
-1.84%
Virtus Silvant Focused Growth R6

CATX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+33.51%
STRR - CATX
88%
Closely correlated
-0.68%
SHC - CATX
36%
Loosely correlated
+0.99%
NVCR - CATX
34%
Loosely correlated
-1.69%
MTD - CATX
31%
Poorly correlated
+0.90%
RVTY - CATX
29%
Poorly correlated
-1.57%
More

Groups containing CATX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+33.51%
Medical/Nursing Services
industry (216 stocks)
-1%
Poorly correlated
-0.81%
Health Services
industry (410 stocks)
-3%
Poorly correlated
-0.91%